Monoclonal antibodies and epitope binning
Rank clones by off-rate to find the slowest dissociating binders.
Measure full kinetics and affinity, with epitope binning to map binding sites.
Each format has its own testing needs. The inQuiQ covers them from one platform.
Rank clones by off-rate to find the slowest dissociating binders.
Measure full kinetics and affinity, with epitope binning to map binding sites.
Confirm that both arms reach their targets.
Sequential and simultaneous assays check each arm separately.
Clean kinetics from low molecular weight formats.
VHH, scFv, and Fab produce only a small mass change on binding.
Check that conjugation has not altered target binding.
Compare the ADC against its parent antibody under the same conditions.
See how Fc changes affect binding to antigen, FcRn in an FcRn binding assay, and proteins.
A temperature series adds thermodynamic detail.
Discuss your application with one of our application specialists.
Four independently addressable flow channels, each carrying four sensors, with the sample flowing through the channels in series.
A small mass change still resolves into a full curve, so VHH, scFv, and Fab return real kinetics.
The binder and its target meet unmodified, and the sensor reads the interaction itself rather than a reporter standing in for it.
The sample flows over the sensor after one filter step, and the antifouling hydrogel reduces non-specific binding. Trusted data, fewer purification steps.
Every antibody binding measurement follows the same five steps. One partner is captured on the sensor, the other flows past, and the binding response is recorded in real time. An ELISA gives one endpoint. The inQuiQ gives the whole curve.
One partner is captured on the sensor surface first.
Antigen coupled directly, or antibody held by a capture reagent. A captured bivalent IgG meets surface-bound antigen with both arms, so the result reflects avidity. Immobilize the antigen instead and you read monovalent affinity.
Any activated site left unused is capped before the sample arrives.
Without capping, the surface keeps reacting with whatever passes over and non-specific binding appears in the trace, unrelated to the pair measured. The response settles at the immobilized amount.
The sample flows across the surface and the response climbs.
Purified protein or crude hybridoma supernatant can both be measured. Flow sets the contact time, which matters for small analytes such as a nanobody or scFv. The rising phase gives the on-rate, ka.
Buffer replaces the sample and the response falls as the complex comes apart.
The dissociation phase gives the off-rate, kd, and can be read on its own, so clones can be ranked before purification. Fit a concentration series for ka, kd, and KD: multi-cycle kinetics, or single-cycle when material is scarce.
A regeneration buffer strips the remaining analyte and returns the sensor to baseline, ready for the next run.
The immobilized partner stays in place throughout affinity maturation of antibodies. Inject, read, regenerate, repeat. Sixteen targets or controls from one sample let antibody specificity testing run alongside affinity measurement.
One benchtop label-free biosensor across the antibody discovery workflow, from antigen binding assays to epitope binning and antibody characterization.
4 channels to read a single injection, so targets and controls are measured together.
Competitive and cross-blocking assays sort a panel into bins.
Single-cycle kinetics and multi-cycle kinetics give the whole curve, not an endpoint.

Sequential and simultaneous assays check that both arms of a bispecific reach their targets.
The temperature-controlled flow cell runs a full temperature series.
Simply add an autosampler, and increase your throughput for library screens.
Immobilize the antigen or capture the antibody on the sensor, then inject a concentration series of the binding partner. The inQuiQ records association and dissociation in real time and fits the data to give binding affinity (KD) and kinetics (kon, koff), across a range of 10 pM to 10 mM, without any label. The same antigen binding assay format supports antibody characterization across every antibody format on this page.
Off-rate ranking sorts candidates by how slowly they release their target, since a slow off-rate (koff) often signals a stronger, longer-lived interaction. The inQuiQ captures each antibody, records dissociation in real time, and ranks the panel by koff,so you can shortlist the slowest dissociating binders early, even from crude supernatant. That covers the material hybridoma screening, phage display screening and yeast display screening actually deliver.
Epitope binning groups a panel of antibodies by the region of the antigen they bind. Antibodies that block each other likely share an epitope, while pairs that bind together fall into different bins. The inQuiQ runs an epitope binning assay by competitive and cross-blocking injection, showing which candidates compete for the same site. Binning narrows a panel before the finer epitope mapping methods, paratope mapping among them, are brought in.
A bispecific must engage both of its targets to work. The inQuiQ confirms this with sequential and simultaneous binding assays: capture the bispecific, inject the first antigen, then the second, and watch whether both bind. You get affinity and kinetics for each arm and confirmation that the molecule bridges both targets, supporting antibody specificity testing and antibody developability decisions.
A nanobody (VHH) is small, so binding produces only a small mass change that some label-free platforms miss. The inQuiQ measures binding across an affinity range of 10 pM to 10 mM and returns full kinetics (kon, koff) and affinity (KD) for VHH, scFv, and Fab formats from as little as 30 µL of sample.
